Product Overview
[Drug Name]
Trade Name: Weihaoshu
English Name: Omeprazole Enteric Capsules
Chinese Pinyin: Aomeilazuo Changrongjiaonang
[Ingredients]
Omeprazole.
[Properties]
This product is a capsule containing small granules in an off-white enteric coating.
[Indications]
Indicated for gastric ulcers, duodenal ulcers, stress ulcers, reflux esophagitis, and Zollinger-Ellison syndrome (gastrinoma).
[Dosage and Administration]
Oral administration, do not chew.
1. Peptic ulcer: Take one capsule once, 1-2 times daily. Swallow in the morning or once in the morning and evening.
2. Reflux esophagitis: Take one to three capsules once, 1-2 times daily. Swallow in the morning or once in the morning and evening.
3. Zollinger-Ellison syndrome: Take three capsules once daily. 4. For duodenal ulcers, the course of treatment is 2-4 weeks; for gastric ulcers and reflux esophagitis, the course of treatment is 4-8 weeks.
[Adverse Reactions]
This product is well tolerated. Common adverse reactions include diarrhea, headache, nausea, and constipation.
[Contraindications]
This product is contraindicated in patients with allergies, severe renal insufficiency, and infants and young children.
[Precautions]
Gastric cancer should be ruled out before using this product. Use with caution in patients with hepatic or renal insufficiency, pregnant women, and lactating women.
[Special Population Use]
Precautions for Children: Contraindicated in infants and young children.
Precautions for Pregnancy and Lactation: Although this product has not been shown to cause teratogenicity in animal studies, it should generally not be used in pregnant women and should also be used with caution in lactating women.
Precautions for the Elderly: Not yet established.
[Drug Interactions]
1. Avoid concomitant use with oral imidazole antifungals such as ketoconazole, itraconazole, miconazole, and fluconazole.
2. Omeprazole combined with clarithromycin may increase the incidence of central nervous system (primarily headache) and gastrointestinal adverse reactions.
3. Avoid concomitant use with diazepam (Valium), phenytoin, warfarin, nifedipine, digoxin, cisapride, quinidine, cyclosporine, caffeine, and theophylline.
4. Concomitant use with other medications may cause drug interactions. Please consult your physician or pharmacist for details.
[Pharmacological Action]
This product selectively targets the proton pump H+, K+-ATPase site in gastric parietal cells, inhibiting the final step of acid secretion in parietal cells. This prevents the use of H+ into the gastric cavity and exerts a strong and long-lasting inhibitory effect on gastric acid secretion induced by various stimuli.
[Storage]
Store in a dry, airtight container away from light.
[Strength]
20mg
[Packaging Size]
20mg*14s
[Expiration]
24 months
[Approval Number]
National Medical Products Approval No. H20033677
